Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Asset Writedowns and Impairment (2016 - 2025)

Eastman Chemical (EMN) has disclosed Asset Writedowns and Impairment for 9 consecutive years, with $5.0 million as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Asset Writedowns and Impairment changed N/A year-over-year to $5.0 million, compared with a TTM value of $5.0 million through Sep 2025, changed 0.0%, and an annual FY2025 reading of $33.0 million, up 560.0% over the prior year.
  • Asset Writedowns and Impairment was $5.0 million for Q3 2024 at Eastman Chemical, down from $11.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $136.0 million in Q2 2020 and bottomed at $1.0 million in Q4 2020.
  • Average Asset Writedowns and Impairment over 3 years is $27.8 million, with a median of $7.0 million recorded in 2020.
  • The sharpest move saw Asset Writedowns and Impairment tumbled 98.61% in 2020, then surged 1000.0% in 2021.
  • Year by year, Asset Writedowns and Impairment stood at $1.0 million in 2020, then soared by 1000.0% to $11.0 million in 2021, then plummeted by 54.55% to $5.0 million in 2024.
  • Business Quant data shows Asset Writedowns and Impairment for EMN at $5.0 million in Q3 2024, $11.0 million in Q4 2021, and $5.0 million in Q2 2021.